Zeming Liu
Union Hospital
Huazhong, 430022, China
Huazhong, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Nanozyme hydrogel for enhanced alkyl radical generation and potent antitumor therapy.
Journal: Nanoscale advances
Published: June 20, 2022
A new proposed tumor-node-metastasis-age staging system for stage IV medullary thyroid carcinoma based on the SEER database.
Journal: American journal of translational research
Published: April 12, 2020
Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching.
Journal: Medicine
Published: August 05, 2018
Prognosis of patients with TX stage differentiated thyroid cancer: propensity scored matching analysis of the SEER database 2004-2013.
Journal: American journal of translational research
Published: September 12, 2017
A potential role for the Hippo pathway protein, YAP, in controlling proliferation, cell cycle progression, and autophagy in BCPAP and KI thyroid papillary carcinoma cells.
Journal: American journal of translational research
Published: March 08, 2017
Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.
Journal: International journal of clinical and experimental pathology
Published: September 17, 2015
Using foci number to predict central lymph node metastases of papillary thyroid microcarcinomas with multifocality.
Journal: International journal of clinical and experimental medicine
Published: April 15, 2015
Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma.
Journal: International journal of clinical and experimental medicine
Published: March 06, 2015
Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma.
Journal: International journal of clinical and experimental medicine
Published: November 05, 2014
Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer.
Journal: International journal of clinical and experimental pathology
Published: November 03, 2014
Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma.
Journal: International journal of clinical and experimental medicine
Published: May 27, 2014
Bortezomib-based chemotherapy regimens can improve response in newly diagnosed multiple myeloma patients with bcl-2 and survivin overexpression.
Journal: International journal of clinical and experimental pathology
Published: May 16, 2014
Last Updated: 09/26/2026